Натиснете тук, за да гледате видеообръщението.

Prof. Galina Velikova, MD, PhD

Professor Galina Velikova is an academic Medical Oncologist at the University of Leeds and Leeds Teaching Hospitals, UK. She obtained her medical degree from the Higher Medical Institute, Varna of the Academy of Medicine, Bulgaria; she specialised in internal medicine in Bulgaria and in medical oncology with Royal College of Physicians, England. Prof Velikova obtained her PhD from University of Leeds, UK.

She is a practising oncologist (Consultant in Medical Oncology) with clinical work focused on systemic treatment of breast cancer patients with early and advanced disease. She is passionate about clinical research and has over 25 years’ track record of successful patient-centred research using electronic Patient-Reported Outcome Measures in daily practice and clinical trials.  She led a National Institute for Health Research (NIHR) 5-year Programme Grant for applied research on patient self-reported symptoms and toxicity, using an online reporting system (QTool), uniquely integrated in electronic records, along re-designed care pathways for remote monitoring during cancer treatment to improve patient safety. Further research projects evaluate the use of the electronic system for remote monitoring and follow-up of cancer patients after treatment. She is currently working on large collaborative Horizon Europe projects (EUOnQOL; MyPath, SISAQOL).

Professor Velikova has experience in leading collaborative research, both nationally and internationally, such as Quality of Life sub-studies of international breast cancer trials (TACT2, SUPREMO).  She is on the Steering Committee for the NHS England national quality-of-life metric project for cancer survivors.  Professor Velikova served as:

– Chair of the National Cancer Research Institute (NCRI) Living with and Beyond Cancer Group (2019-23); 

– Board member of the European Organisation for Research and Treatment of Cancer (EORTC) (2018-21);

– President of the International Society for Quality of Life Research (ISOQOL) (2013-15); 

– Chair of the (EORTC) Quality of Life Group (2008-11); 

– Chair of the British Psychosocial Oncology Society (2006-10); 

Добавете тук текста на заглавието

Сфинксът на българската онкология

Видеообръщение на доц. д-р Димитър Калев